SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005201-20-000007
Filing Date
2020-02-06
Accepted
2020-02-06 17:49:27
Documents
2
Period of Report
2020-02-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_158102934947233.html 4  
1 FORM 4 wf-form4_158102934947233.xml 4 9748
2 PEISERTPOA2020 peisertpoa2020.htm EX-24 3233
  Complete submission text file 0001005201-20-000007.txt   14504
Mailing Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045
Business Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Therapeutics, Inc (Issuer) CIK: 0001005201 (see all company filings)

IRS No.: 943229046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ASSERTIO THERAPEUTICS, INC. 100 SOUTH SAUNDERS ROAD, SUITE 300 LAKE FOREST IL 60045
Business Address
Peisert Daniel A. (Reporting) CIK: 0001758376 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13111 | Film No.: 20583903